The Math Shows PJP Can Go To $74 Friday, February 14, 8:58 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
The Implied Analyst 12-Month Target For PWC Friday, March 27, 8:27 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Add Up The Parts: PJP Could Be Worth $76 Friday, June 26, 8:43 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Surprising Analyst 12-Month Target For PJP Thursday, September 10, 8:13 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
TARO Makes Bullish Cross Above Critical Moving Average
By Market News Video Staff, Friday, November 13, 4:02 PM ET
In trading on Friday, shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) crossed above their 200 day moving average of $64.56, changing hands as high as $65.60 per share. Taro Pharmaceutical Industries Ltd. shares are currently trading up about 6.4% on the day. The chart below shows the one year performance of TARO shares, versus its 200 day moving average:
Looking at the chart above, TARO's low point in its 52 week range is $53.9462 per share, with $99.69 as the 52 week high point — that compares with a last trade of $65.30.
This Article's Word Cloud:AboveAverageCrossingDaysDollarsFridayIndustriesJoinLookingMovingNYSEOfferPharmaceuticalSevenSpecialStartStocksTAROTaroTheirValueForumaboutaboveaveragebelowchangingchartcomparesconversationcrossedcurrentlyhandshighincomeinvestinginvitationlastmdashmovingperformancepointrangeraquosharesharesshowsslideshowtradingweekwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.